• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Medisafe, Nestlé Health Science Integrate to Improve Patient Health

by HITC Staff 03/15/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

medisafe virtual pill box

Medisafe®, the personalized mHealth platform for medication management, announced today a new collaboration with Nestlé Health Science, a health science company that is advancing the role of nutritional therapy to improve patient health. The partnership aims to realize the proven benefits of compliance to the proper regimen ofIMPACT ADVANCED RECOVERY Specialized Nutrition Drink to address the unique nutritional needs of major elective surgery patients at risk of infection.

The companies will work with clinical teams at a number of major hospital systems across the U.S. to help patients install Medisafe on their smart devices when their treating physicians recommend IMPACT ADVANCED RECOVERY Drink. Patients who have received a recommendation from their healthcare professionals to consume IMPACT ADVANCED RECOVERY Drink will receive Medisafe alerts reminding them when it’s time for each recommended serving. It will also display educational content provided by Nestlé Health Science. They will also have access to all Medisafe features and functionality, including management of any medications, “Medfriend” caregiver support, and a feed of additional content and resources tailored to their individual circumstances.

This collaboration with Nestlé Health Science initially focuses on the five-to-ten day perioperative window (before and after surgery) for major elective surgery patients.

“Partnering with Nestlé Health Science is one in a series of initiatives that will make Medisafe available to healthcare providers so that they can help people take more control of their health,” said Jon Michaeli, Medisafe’s EVP Marketing and Business Development. “This partnership comes on the heels of our recent Medisafe Providers launch, showing our commitment to build tools within the platform for physicians and care teams to support their patients’ compliance on an ongoing basis.”

The potential benefit of the Medisafe/Nestlé Health Science joint offering is substantial. “In study after study, strong compliance to IMPACT® formulas in the perioperative protocol has been shown to support the immune system to help promote recovery after major elective surgery,” said Hoddy Klein, Vice President of Medical Nutrition Marketing North America for Nestlé Health Science. “We believe the Medisafe application has the potential to significantly increase adherence to the IMPACT protocol that is recommended for certain major elective surgery patients by their healthcare professionals, and we look forward to seeing the positive results of this collaboration in the months ahead.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |